Consensus Akoya Biosciences, Inc.

Equities

AKYA

US00974H1041

Real-time Estimate Cboe BZX Other stock markets 13:37:40 2024-05-15 EDT			5-day change	1st Jan Change
2.78 ^USD	-4.14%		-32.36%	-43.03%

02:12pm	Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating	MT
05-14	Top Midday Decliners	MT

Evolution of the average Target Price on Akoya Biosciences, Inc.

Price target over the last 5 years

History of analyst recommendation changes

36ba.gyMARUBTxZE4sSF3MbxMI7hsj2tpq3l0ReJNcYfBlD8.1nNfF3YhisRAgFM4RI04ZtMp9xoY4DsZP5omP7aU9XfJaVY0DDWKqGD7dA~8e1300615f3ce90366e9b9cbe41f2290

Analyst Recommendations on Akoya Biosciences, Inc.

Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating	08:12am	MT
JPMorgan Adjusts Price Target on Akoya Biosciences to $10 From $12, Maintains Overweight Rating	03-06	MT
UBS Adjusts Akoya Biosciences Price Target to $7.50 From $7, Maintains Buy Rating	03-05	MT
Stephens Adjusts Price Target on Akoya Biosciences to $9 From $14, Maintains Overweight Rating	11-13	MT
Morgan Stanley Adjusts Akoya Biosciences' Price Target to $8 From $15, Keeps Overweight Rating	23-10-24	MT
UBS Cuts Akoya Biosciences Price Target to $7 From $12, Maintains Buy Rating	23-10-12	MT
UBS Adjusts Akoya Biosciences Price Target to $12 From $13, Maintains Buy Rating	23-08-08	MT
Morgan Stanley Adjusts Price Target on Akoya Biosciences to $15 From $16, Maintains Overweight Rating	23-08-08	MT
Morgan Stanley Adjusts Price Target on Akoya Biosciences to $16 From $17, Maintains Overweight Rating	23-05-10	MT
UBS Adjusts Akoya Biosciences Price Target to $13 From $14, Maintains Buy Rating	23-05-09	MT
Morgan Stanley Adjusts Price Target on Akoya Biosciences to $17 From $18, Maintains Overweight Rating	23-03-08	MT
UBS Initiates Coverage on Akoya Biosciences With Buy Rating, $14 Price Target	23-02-02	MT
Capital One Initiates Akoya Biosciences at Overweight Rating With $19 Price Target	22-11-03	MT
Stephens Starts Akoya Biosciences at Overweight With $16 Price Target	22-10-06	MT
Piper Sandler Adjusts Price Target on Akoya Biosciences to $17 From $14, Reiterates Overweight Rating	22-08-18	MT
BTIG Starts Akoya Biosciences at Buy With $16 Price Target	22-06-22	MT
Piper Sandler Adjusts Price Target on Akoya Biosciences to $14 From $18, Reiterates Overweight Rating	22-05-16	MT
Morgan Stanley Trims Akoya Biosciences Price Target to $18 From $19, Maintains Overweight Rating	22-05-09	MT
Piper Sandler Adjusts Price Target on Akoya Biosciences to $18 From $23, Reiterates Overweight Rating	22-03-17	MT
JPMorgan Adjusts Akoya Biosciences' Price Target to $20 from $25, Keeps Overweight Rating	22-03-15	MT
Morgan Stanley Adjusts Akoya Biosciences' Price Target to $19 from $20, Keeps Overweight Rating	22-03-15	MT
Morgan Stanley Adjusts Akoya Biosciences Price Target to $20 From $24, Maintains Overweight Rating	22-02-15	MT
AKOYA BIOSCIENCES : Canaccord Genuity Starts Akoya Biosciences at Buy With $25 Price Target	21-05-11	MT
AKOYA BIOSCIENCES : JPMorgan Starts Akoya Biosciences at Overweight With $23 Price Target	21-05-11	MT
AKOYA BIOSCIENCES : Morgan Stanley Starts Akoya Biosciences at Overweight With $26 Price Target	21-05-11	MT